The role of vasodilator agents in the emergency treatment of heart failure
You, K.
Zhonghua Nei Ke Za Zhi 22(2): 111-114
1983
ISSN/ISBN: 0578-1426 PMID: 6409536 Document Number: 220656
Document emailed within 1 workday
Related Documents
Lloyd, E.A. 1979: The use of vasodilator agents in the treatment of heart failure South African Medical Journal 56(20): 787-795Cleland, J.G. 1994: Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents? British Journal of Hospital Medicine 52(5): 193; 195-196
Just, H.; Drexler, H.; Holubarsch, C. 1988: Therapy of heart failure with vasodilator agents Zeitschrift für Kardiologie 77(Suppl 5): 97-101
Corbalán, R.; Kunstmann, S.; Jalil, J. 1993: Vasodilator agents in chronic heart failure: which is the best option? Revista Medica de Chile 121(1): 81-88
Pierach, C.A.; Jarosch, P.F. 1974: Treatment of heart failure with vasodilator drugs Münchener Medizinische Wochenschrift 116(39): 1689-1690
Pawlik, W.W.; Waluś, K.M.; Gustaw, P.; Konturek, S.J. 1981: Action of vasodilator agents in experimental mesenteric circulatory failure Folia Medica Cracoviensia 23(2): 155-168
Mason, D.T.; Awan, N.A.; Demaria, A.N.; Lee, G.; Joye, J.A.; Amsterdam, E.A. 1979: Vasodilator therapy for chronic heart failure Comprehensive Therapy 5(7): 6-14
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Ito, T.; Matsumoto, S.; Ito, Y. 1978: Chronic heart failure and vasodilator therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3565-3572
Bower, P.J. 1982: Vasodilator therapy in congestive heart failure Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 134(2): 36-39
Ypenburg, C.; Verwey, H.F.; van der Wall, E.E. 2007: Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner Nederlands Tijdschrift Voor Geneeskunde 151(44): 2426-2428
Groden, D.L. 1993: Vasodilator therapy for congestive heart failure. Lessons from mortality trials Archives of Internal Medicine 153(4): 445-454
Hertzeanu, H.; Pines, A. 1988: New inotropic agents in the treatment of refractory congestive heart failure Harefuah 114(6): 290-293
Lechat, P. 1989: Treatment of chronic heart failure with positive inotropic agents Therapie 44(6): 437-445
Artese, D.; Albani, A.; Di Tomasso, E. 1983: Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution Minerva Medica 74(13): 715-722
Marqués Sala, R. 1970: Use of vasodilator agents in the treatment of shock Revista Espanola de Anestesiologia y Reanimacion 17(4): 717-720
Rusca, M.; Liaudet, L. 2009: Inotropic agents for treatment of acute heart failure syndromes in intensive care Revue Medicale Suisse 5(229): 2512-2515
Mauri, F.; Gronda, E.; Bossi, M.; Rovelli, F. 1980: Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside I.v. and oral prazosin Giornale Italiano di Cardiologia 10(4): 414-423
Ostrzycki, A.; Kochmański, M. 1988: Vasodilator agents in the treatment of acute myocardial infarction Polski Tygodnik Lekarski 43(36): 1139-1142
Kersting, F.; Samosny, G.; Kasper, W.; Schuster, H.P. 1981: Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure Die Medizinische Welt 32(26): 1040-1045